Clinical and Experimental Ophthalmology

Article	Citations
Continuing Professional Development	123
Issue Information	103
Issue Information	81
Genetics in neovascular age‐related macular degeneration susceptibility and treatment response to anti‐VEGF intravitreal injection: A case series study	65
The Long Journey of Treatment for Wet Macular Degeneration, Is It Worth It?	59
Proposal of a Simpler Eye‐Level Risk Model Incorporating Reticular Pseudodrusen for the Clinical Prediction of Late Age‐Related Macular Degeneration	48
Mimickers of hydroxychloroquine retinal toxicity	47
Improved methods for isolating the mouse retinal vasculature	46
The association between keratoconus and allergic eye diseases: A systematic review and meta‐analysis	43
Circular RNA expression profile and functional analysis of circUvrag in light‐induced photoreceptor degeneration	36
Stromal Curvature, Power and Corneal‐Stromal Curvature Ratios From a Hybrid AS ‐ OCT in Eyes With	31
Uveal Melanoma Treatment: An Update	30
Recent advances in the use of optical coherence tomography in neuro‐ophthalmology: A review	29
Telemedicine and delivery of ophthalmic care in rural and remote communities: Drawing from Australian experience	29
Issue Information	28
	27
Continuing Professional Development	26
Continuing Professional Development	26
Issue Information	26
‘Closing the gap’ on visual acuity outcomes of Indigenous and remote patients receiving intravitreal injections in Northern Australia	25
	23
Global challenges in the management of diabetic retinopathy in women with pre‐gestational diabetes	23
	22
Gender differences in retinal diseases: A review	22
Comparison of various treatment modalities in patients with primary vitreoretinal lymphoma: A systematic review and meta‐analysis	21

Enhancing Detection and Diagnosis of Intraocular Lymphoma Through Advanced Retinal Imaging	21
Phenotypic Spectrum of Early Onset Angle Closure Glaucoma in Young Indian Patients	20
Is it time to consider how we approach bilateral same‐day cataract surgery?	20
Continuing Professional Development	20
Bevacizumab biosimilar (bevacizumab‐awwb) is safe in the treatment of retinopathy of prematurity	20
Repeat Intraocular Sampling and Microbiological Testing in Infectious Endophthalmitis: Response	19
Management of macular oedema due to retinal vein occlusion: An evidence‐based systematic review and meta‐analysis	19
	19
Social determinants of health and health disparities in glaucoma: A review	19
Issue Information	18
Issue Information	18
Optimising the Evaluation of Optic Neuritis YouTube Videos: A Call for Multimedia‐Specific Tools and Audience‐Oriented Approaches—Response	17
Bridging healthcare disparities in diabetic retinopathy care: Insights from Sri Lanka	17
Seasonal Trends in HLA‐B27‐Associated Uveitis: A Commentary on Recent Findings	17
Visual Acuity Alone Is Not Enough: The Need for Multimodal Biomarkers in Dominant Optic Atrophy—Response	17
	16
Long‐term limitations and complications of trans‐scleral diode laser cycloablation for refractory glaucoma	16
Chronic Kidney Disease and Glaucoma: Is the Case Truly Closed?	15
Film Abstracts	15
Topical Dorzolamide for Macular Holes: A Randomised, Double‐Blind, Placebo‐Controlled Trial–Comment	15
Corneal endothelial evaluations in immunoglobulin g4‐related ophthalmic disease	14
Environmental influences on ophthalmic conditions: A scoping review	14
Myopia progression following 0.01% atropine cessation in Australian children: Findings from the Western Australia – Atropine for the Treatment of Myopia (WA‐ATOM) study	14
Comparison of metabolic profiles in aqueous humour of Fuchs' syndrome and presumed viral‐induced anterior uveitis patients	14
Seasonal Variation in HLA ‐ B27 Associated Uveitis	14
Surgical Techniques for the Virna Glaucoma Implant: A Low‐Cost New Glaucoma Drainage Device—Response	14
Intraocular Metastasis: Differential Diagnosis and Management	14
Issue Information	13
Prediction of refraction error after toric lens implantation with biometric input data uncertainties and power labelling tolerances	13
Dr AI will see you now	13
Randomised controlled trial on robot‐assisted versus manual surgery for pucker peeling	13
	13
Evaluation of ChatGPT‐4 responses to glaucoma patients' questions: Can artificial intelligence become a trusted advisor between doctor and patient?	13
Are There Biomechanical Changes in Tomographically Progressive Keratoconus Corneas?	12
Correction to ‘Prediction of refraction error after toric lens implantation with biometric input data uncertainties and power labelling tolerance’	12
A Chat About Peer Review	12
Australian Pharmaceutical Benefits scheme data on utilisation of intravitreal therapy in retinal vein occlusion	12
Preventing Shunt Launch: A Novel Technique for Extraocular Flushing of the PreserFlo MicroShunt	11
Leber Hereditary Optic Neuropathy: Support, Genetic Prediction and Accurate Genetic Counselling Enhance Family Planning Choices	11
Australia's Rising Rates of Intravitreal Injections: Forecasting the Demand for Intravitreal Injections in Australia Using Data From the Pharmaceutical Benefits Scheme	11
Retinal Vascular Phenotyping: Prospective Roadmap for Multimodal Integration and Clinical Translation in Systemic Health	11
Predictive Factors for Uveitis Refractory to Treatment in Initial‐Onset Acute Vogt‐Koyanagi‐Harada Disease	11
Reflections on the Safety and Stability of the Second‐Generation Suprachoroidal Retinal Prosthesis	11
Orbital Rhabdomyosarcoma: A Comprehensive Review of Clinical Features, Molecular Advances and Current Management	11
Insights into the diagnosis and management of sarcoid uveitis: A review	10
Saturday 02 November	10
Central serous chorioretinopathy: A review	10
Keratoconus in Down syndrome: Prevalence, risk factors, severity and corneal tomographic characteristics	10
Intraocular Metastasis: Global Oncologic Perspective With Emphasis on Breast Lobular Carcinoma	10
Issue Information	10

Antimicrobial stewardship in ocular infections: Fourteen years of over‐the‐counter chloramphenicol in Australia	10
Ophthalmic Adverse Events of Systemic Immunotherapy and Targeted Cancer Therapy: A Review	10
Saturday 29 October Speakers	10
Comparative Study of Trabeculectomy, PRESERFLO MicroShunt and XEN45 Gel Stent in Open‐Angle Glaucoma	9
Evaluation of ocular surface following PreserFlo Microshunt implantation: Functional outcomes and quality of life	9
Diagnostic Ability of Transverse Axial Images Obtained by Optical Coherence Tomography for Detecting Anterior Displacement of Peripapillary Tissues in Papilledema	9
Longitudinal Visual Biomarkers in Dominant Optic Atrophy: A Systematic Review and Meta‐Analysis	9
Evaluation of mild periorbital cellulitis and home‐based therapy in children—EPOCH study: A prospective single centre cohort study	9
Femtosecond Laser Created Corneal Allogenic Intrastromal Ring Segments for Keratoconus	9
Saturday 15 November	9
Outcomes of cataract surgery in paediatric uveitis: A multisite study	9
Reflections on the Safety and Stability of the Second‐Generation Suprachoroidal Retinal Prosthesis: Response	9
Outcomes of Stent Removal in Eyes With the Paul Glaucoma Implant With Intraluminal 6–0 Polypropylene	9
Duration‐Dependent Efficacy and Clinical Safety of Repeated Low‐Level Red‐Light Therapy for Paediatric Myopia: A Systematic Review and Meta‐Analysis	9
AI: From productivity dividend to better patient outcome	9
Epidemiology of monocanalicular stenting in paediatric lacrimal canalicular trauma	9
Te hauora karu o te iwi Māori: A comprehensive review of Māori eye health in Aotearoa/New Zealand	9
Retreatment interval lengthening achieved in two thirds of eyes with prolonged intensive anti‐VEGF therapy for neovascular age‐related macular degeneration after switching to faricimab	9
Nocturnal hypoxia and age‐related macular degeneration	9
Utilisation of Genetic Testing of Inherited Retinal Diseases in an Australian Public Tertiary Hospital Setting	8
A Microsurgical Skills Course Improves Cataract Surgery Proficiency in First Year Australia and New Zealand Ophthalmology Trainees	8
	8
Biomarkers in age‐related macular degeneration	8
Issue Information	8
Impact of glucagon‐like peptide‐1 receptor agonists on diabetic retinopathy: A meta‐analysis of clinical studies emphasising retinal changes as a primary outcome	8
Issue Information	8
Safety of an Intravitreal Bevacizumab Biosimilar ( MVASI )	8
Detecting Glaucoma in Highly Myopic Eyes From Fundus Photographs Using Deep Convolutional Neural Networks	8
Evaluation of moderate periorbital cellulitis and home‐based therapy in children (EPOCH study, Part 2): A prospective single centre cohort study	8
Global retinoblastoma studies: A review	7
Seeking best outcomes for patients living with vitreoretinal lymphoma	7
Continuing Professional Development	7
The Impact of Lions Outback Vision's Kimberley Hub on Cataract Surgery Rate and Wait Time in Rural Western Australia: An Interrupted Time Series Analysis	7
Eyes Offshore: Reporting the Eye Health Needs of Refugees and Asylum Seekers in Australia's Offshore Detention Centres	7
A retinal endothelial cell barrier is disrupted by direct contact with retinal Müller glial cells in vitro	7
Reliability of surgical memory and self‐report in patients with prior strabismus surgery	7
Prediction of refraction error after toric lens implantation with biometric input data uncertainties and power labelling tolerances: Response	7
Retinal Gene Therapy: Perceptions of Ophthalmologists in Australia and New Zealand	7
Current understanding of subclinical diabetic retinopathy informed by histology and high‐resolution in vivo imaging	7
Ageing and retinal thickness: An important association	7
Natural history and biomarkers of KCNV2‐associated retinopathy	6
	6
Effect of Continuous Positive Airway Pressure on Intraocular Pressure in Patients With Obstructive Sleep Apnoea: A Systematic Review and Meta‐Analysis	6
	6
Continuing Professional Development	6
	6
Predictability of success for combined iStent inject trabecular bypass implantation with phacoemulsification in the subsequent eye	6
Incidence, Progression and Determinants of Diabetic Retinopathy in Type 2 Diabetes in Australasia: A Systematic Review and Meta‐Analysis	6
Issue Information	6
Film Abstracts	6
Low‐concentration atropine eyedrops for myopia control in a multi‐racial cohort of Australian children: A randomised clinical trial	6
Diabetic Retinopathy During Pregnancy: Implications of Intensive Control Prior to Pregnancy With Incretin Mimetic Therapy in Type 2 Diabetes Mellitus	6
One‐year real‐world outcomes of bevacizumab for the treatment of macular oedema secondary to retinal vein occlusion	6
Comparison of intraocular pressure and anterior segment parameters in subjects with asymmetrical primary angle closure disease	6
Continuing Professional Development	6
The Challenge of Managing Paediatric Periorbital Cellulitis	6
Surgical Techniques for the Virna Glaucoma Implant: A Low‐Cost New Glaucoma Drainage Device	5
Aqueous Humour Cytokines as Predictors of Axial Elongation in High Myopia: A 2‐Year Longitudinal Cohort Study	5
Invited Speakers	5
Randomised Controlled Trial: Influence of Subconjunctival Anaesthesia Duration on Pain Perception During Intravitreal Injections: Response	5
Issue Information	5
	5
Optic nerve sheath fenestration for treating papilloedema in the era of cerebral venous sinus stenting	5
Twelve‐Month Real‐World Outcomes of Faricimab for Treatment‐Naive Neovascular AMD in Australia	5
Reactivation of stable neovascular age‐related macular degeneration following treat‐and‐extend regimen discontinuation	5
Continuing Professional Development	5
Efficacy of oral doxycycline in the treatment of recurrent corneal erosion syndrome	5
Evidence on the Use of Topical Ciclosporin for Ocular Surface Disease: A Systematic Review and Meta‐Analysis—Response	5
Past Lecturers and Briefs for the Named Lectures: RANZCO Annual Scientific Congress	5
Real‐world outcomes of low‐dose atropine therapy on myopia progression in an Australian cohort during the COVID‐19 pandemic	5
Issue Information	5
Endophthalmitis After Dexamethasone Implant	5
The enigma of corneal astigmatism	5
Film Abstracts	5
The Burden of Keratoconus in the Pacific Islands	5
	5
CONTINUING PROFESSIONAL DEVELOPMENT	5
Topical dorzolamide for macular holes: A randomised, double‐blind, placebo‐controlled trial	5
Monday 17 November	5
Visual fields in glaucoma: Where are we now?	4

Preclinical biocompatibility and biosafety evaluation of a new foldable brown diaphragm intraocular lens: An in vitro and in vivo study	4
The Royal Australian and New Zealand College of Ophthalmologists, 55th Annual Scientific Congress 1 – 4 November 2024Adelaide Convention Centre	4
Scientific Program	4
Systematic review and appraisal of quality, definitions and treatment recommendations of clinical guidelines for glaucoma suspects	4
Adalimumab Monotherapy or Combination Therapy With Methotrexate in Paediatric Uveitis: Data From the AIDA Network Uveitis Registry	4
Should this artificial intelligence algorithm be used in my practice now? A checklist approach: Response	4
Sustained and rebound effect of repeated low‐level red‐light therapy on myopia control: A 2‐year post‐trial follow‐up study	4
The challenge in the diagnosis and management of vitreoretinal lymphoma	4
Retention time of different ophthalmic viscosurgical devices during phacoemulsification in rabbit ocular model: A comparative analysis	4
Utilisation of patient‐centred outcome measures in age‐related macular degeneration research and clinical practice: A systematic review	4
A novel genomic rearrangement on chr19q13.42 leads to PRPF31‐associated retinitis pigmentosa	4
Clinical and Experimental Ophthalmology Goes Paperless in 2026	4
	4
Deep learning in optical coherence tomography: Where are the gaps?	4
Association of obesity and metabolic syndrome with incident primary open angle glaucoma in the UK Biobank	4
Invited Speakers	4
Continuing Professional Development	4
Clinical outcomes of fiducial‐free proton beam therapy in Asian patients with uveal melanoma	4
Assessing the carbon footprint of fluorinated gases in vitreoretinal surgery	4